Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2411 studies found for:    Pulmonary Disease, Chronic Obstructive
Show Display Options
Rank Status Study
21 Completed
Has Results
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
22 Completed PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Pulmonary Emphysema;   Chronic Bronchitis
Interventions: Drug: PROCHYMAL™;   Drug: Placebo
23 Completed
Has Results
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Combivent CFC-MDI;   Drug: Combivent Respimat 20/100 mcg;   Drug: Atrovent HFA 42 mcg + Albuterol HFA 200 mcg
24 Completed A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Airway Disease
Interventions: Drug: GW856553;   Drug: Placebo;   Drug: Seretide
25 Completed
Has Results
Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237;   Drug: Placebo
26 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Osteopenia
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
27 Completed
Has Results
12 / 48 wk Pivotal PFT vs PBO in COPD II
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744);   Drug: Placebo
28 Completed
Has Results
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444
29 Completed
Has Results
12 / 48 Week Pivotal PFT vs PBO in COPD I
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI1744);   Drug: placebo
30 Completed
Has Results
Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients
Conditions: Pulmonary Disease, Chronic Obstructive;   Major Depression
Interventions: Behavioral: Treatment Adherence Intervention;   Behavioral: Enhanced Care
31 Completed
Has Results
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Glycopyrronium bromide;   Drug: Placebo to glycopyrronium bromide;   Drug: Tiotropium
32 Completed
Has Results
Sildenafil for Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Emphysema
Interventions: Drug: sildenafil citrate;   Drug: Placebo
33 Active, not recruiting Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Emphysema;   Bronchitis, Chronic
Intervention:
34 Completed Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804;   Drug: Placebo
35 Completed
Has Results
Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone/salmeterol combination (FSC) 250/50mcg;   Drug: tiotropium;   Drug: ipratropium bromide alone or in fixed dose combination with albuterol
36 Completed
Has Results
Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Tiotropium
37 Completed Abdominal Functional Electrical Stimulation to Reduce Hyperinflation in Chronic Obstructive Pulmonary Disease Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: Abdominal Stimulation - low / early;   Device: Abdominal stimulation - low/late;   Device: Abdominal Stimulation - low/full;   Device: Abdominal stimulation - med/early;   Device: Abdominal stimulation - med/late;   Device: Abdominal Stimulation - med/full;   Device: Abdominal Stimulation - high/early;   Device: Abdominal Stimulation - high/late;   Device: Abdominal Stimulation - high/full
38 Completed
Has Results
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder;   Drug: FF Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo
39 Completed
Has Results
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo
40 Suspended High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Respiratory Insufficiency
Intervention: Device: Vapotherm High Flow Therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years